- InMode (INMD, Financial) expects Q2 2025 revenue between $95.4 million and $95.5 million with a strong non-GAAP gross margin of 79-80%.
- Full-year 2025 revenue guidance revised down to $365-$375 million from $395-$405 million due to market weakness and U.S. economic uncertainty.
- Q2 2025 financial results to be released on July 30, 2025, followed by a conference call.
InMode Ltd. (INMD), a global leader in medical technology, has provided preliminary insights into its Q2 2025 financial performance, forecasting revenue in the range of $95.4 million to $95.5 million. The company anticipates maintaining a robust non-GAAP gross margin between 79% and 80% for the quarter.
The company has, however, lowered its full-year 2025 revenue guidance to $365 million to $375 million, a decrease from the previously projected $395 million to $405 million. This adjustment reflects ongoing market challenges and uncertainty in the U.S. economic landscape.
A comprehensive breakdown of the financial results will be provided during a scheduled conference call on July 30, 2025, at 8:30 a.m. Eastern Time. Stakeholders and interested parties are encouraged to pre-register for the call to facilitate swift access on the day of the event.
